Independent Satellite Symposium by Plus Therapeutics presented at the 2024 SNO/ASCO CNS Metastases Conference in Denver, CO.
"Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases," hosted by Plus Therapeutics, will delve into cutting-edge advancements in the diagnosis and treatment of Leptomeningeal Metastases (LM).
Greg Fuller, MD, PhD, from The University of Texas MD Anderson Cancer Center and Plus Therapeutics, will kick off the session with an extensive exploration of the neuropathological aspects of Leptomeningeal Metastasis (LM). Seema Nagpal, MD, from Stanford University, will then discuss innovative cerebrospinal fluid (CSF)-based diagnostic approaches...